BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 21317895)

  • 1. The hidden energetics of ligand binding and activation in a glutamate receptor.
    Lau AY; Roux B
    Nat Struct Mol Biol; 2011 Mar; 18(3):283-7. PubMed ID: 21317895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-Serine Potently Drives Ligand-Binding Domain Closure in the Ionotropic Glutamate Receptor GluD2.
    Chin AC; Yovanno RA; Wied TJ; Gershman A; Lau AY
    Structure; 2020 Oct; 28(10):1168-1178.e2. PubMed ID: 32735769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the binding determinants of the glutamate agonist with the glutamate receptor ligand binding domain.
    Speranskiy K; Kurnikova M
    Biochemistry; 2005 Aug; 44(34):11508-17. PubMed ID: 16114887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retour aux sources: defining the structural basis of glutamate receptor activation.
    Dawe GB; Aurousseau MR; Daniels BA; Bowie D
    J Physiol; 2015 Jan; 593(1):97-110. PubMed ID: 25556791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of a glutamate-receptor ligand-binding core in complex with kainate.
    Armstrong N; Sun Y; Chen GQ; Gouaux E
    Nature; 1998 Oct; 395(6705):913-7. PubMed ID: 9804426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A conformational intermediate in glutamate receptor activation.
    Lau AY; Salazar H; Blachowicz L; Ghisi V; Plested AJ; Roux B
    Neuron; 2013 Aug; 79(3):492-503. PubMed ID: 23931998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular dynamics simulations of the conformational changes of the glutamate receptor ligand-binding core in the presence of glutamate and kainate.
    Mendieta J; Ramírez G; Gago F
    Proteins; 2001 Sep; 44(4):460-9. PubMed ID: 11484223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutamate receptor ion channels: where do all the calories go?
    Mayer ML
    Nat Struct Mol Biol; 2011 Mar; 18(3):253-4. PubMed ID: 21372852
    [No Abstract]   [Full Text] [Related]  

  • 9. Emerging structural explanations of ionotropic glutamate receptor function.
    McFeeters RL; Oswald RE
    FASEB J; 2004 Mar; 18(3):428-38. PubMed ID: 15003989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotransmitter Funneling Optimizes Glutamate Receptor Kinetics.
    Yu A; Salazar H; Plested AJR; Lau AY
    Neuron; 2018 Jan; 97(1):139-149.e4. PubMed ID: 29249286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of the Arabidopsis Glutamate Receptor-like Channel GLR3.2 Ligand-Binding Domain.
    Gangwar SP; Green MN; Michard E; Simon AA; Feijó JA; Sobolevsky AI
    Structure; 2021 Feb; 29(2):161-169.e4. PubMed ID: 33027636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Energetics of Glutamate Binding to an Ionotropic Glutamate Receptor.
    Yu A; Lau AY
    J Phys Chem B; 2017 Nov; 121(46):10436-10442. PubMed ID: 29065265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population Shift Mechanism for Partial Agonism of AMPA Receptor.
    Oshima H; Re S; Sakakura M; Takahashi H; Sugita Y
    Biophys J; 2019 Jan; 116(1):57-68. PubMed ID: 30573176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced efficacy without further cleft closure: reevaluating twist as a source of agonist efficacy in AMPA receptors.
    Birdsey-Benson A; Gill A; Henderson LP; Madden DR
    J Neurosci; 2010 Jan; 30(4):1463-70. PubMed ID: 20107073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology and Structural Analysis of Ligand Binding to the Orthosteric Site of Glutamate-Like GluD2 Receptors.
    Kristensen AS; Hansen KB; Naur P; Olsen L; Kurtkaya NL; Dravid SM; Kvist T; Yi F; Pøhlsgaard J; Clausen RP; Gajhede M; Kastrup JS; Traynelis SF
    Mol Pharmacol; 2016 Feb; 89(2):253-62. PubMed ID: 26661043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of the receptor conformation for iGluR2 agonist binding: QM/MM docking to an extensive conformational ensemble generated using normal mode analysis.
    Sander T; Liljefors T; Balle T
    J Mol Graph Model; 2008 Jun; 26(8):1259-68. PubMed ID: 18203639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding site flexibility: molecular simulation of partial and full agonists within a glutamate receptor.
    Arinaminpathy Y; Sansom MS; Biggin PC
    Mol Pharmacol; 2006 Jan; 69(1):11-8. PubMed ID: 16219907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational analysis of NMDA receptor GluN1, GluN2, and GluN3 ligand-binding domains reveals subtype-specific characteristics.
    Yao Y; Belcher J; Berger AJ; Mayer ML; Lau AY
    Structure; 2013 Oct; 21(10):1788-99. PubMed ID: 23972471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of partial agonism in AMPA-type glutamate receptors.
    Salazar H; Eibl C; Chebli M; Plested A
    Nat Commun; 2017 Feb; 8():14327. PubMed ID: 28211453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective agonist binding of (S)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid (AMPA) and 2S-(2alpha,3beta,4beta)-2-carboxy-4-(1-methylethenyl)-3-pyrrolidineacetic acid (kainate) receptors: a molecular modeling study.
    Pentikäinen OT; Settimo L; Keinänen K; Johnson MS
    Biochem Pharmacol; 2003 Dec; 66(12):2413-25. PubMed ID: 14637199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.